Gene study reveals how MS drug works in chinese patients
NCT ID NCT04410965
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 26 times
Summary
This study looked at how a specific gene change (ABCG2 mutation) affects the amount of the MS drug teriflunomide in the body and its safety. 82 Chinese adults with relapsing multiple sclerosis took the drug once daily for 24 weeks. Researchers measured drug levels and tracked side effects to understand the gene's role.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number
China, China
Conditions
Explore the condition pages connected to this study.